Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Can Couples With Mcv≥80, Mch<26, Hba2<3.2, Hbf<3 Be Classified As Low-Risk Β-Thalassemia Group? Publisher Pubmed



Mirzakhani M1 ; Tarrahi MJ1 ; Baghersad A2 ; Maracy MR1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran
  2. 2. Department of Genetics, Diseases Control Center, Ministry of Health and Medical Education, Tehran, Iran

Source: Journal of Pediatric Hematology/Oncology Published:2019


Abstract

Background and Aim:Thalassemia screening instructions in Iran categorizes couples with mean corpuscular volume (MCV)=75 to 80, mean corpuscular hemoglobin (MCH)=26 to 27, hemoglobin A2 (HbA2)<3.5, and hemoglobin fetal (HbF)<3 indices as low-risk couples, and therefore further genetic testing is not obligatory. This study examined the possibility of classifying couples with MCH<26 and MCV≥80 indices in the low-risk group when their HbF was <3 and HbA2 was <3.2.Methodology:This was a cross-sectional study. The data included results from cell blood count and HbA2 prenatal diagnosis (PND) and HbF tests taken by 22 health care centers in Esfahan province, central Iran, throughout the years 2012-2016. The inclusion criterion was the registering of MCV, MCH, and PND results of the participants. From the 5804 participants, 5624 individuals were included in the study.Results:The sensitivity and specificity of the screening program were 99.7 and 53.12, respectively. Ten cases (0.18%) with thalassemia trait had indices MCV≥80 and MCH≥26 including 3 cases (0.05%) with concurrent α and β-thalassemia mutations and 7 cases (0.12%) with HbS mutations. Altogether, 553 subjects (9.83%) had MCV≥80 and MCH<26 indices, and only 1 case (0.018%) was found with β-thalassemia mutations (codon8 (-AA)/WT genotype).Conclusions:Subjects with MCV≥80, MCH<26, HbA2<3.2, and HbF<3 cell blood count indices could be grouped as low-risk couples if normal HbA2 and HbF values are considered. The results of this study also indicate that there is a chance of missing concurrent α and β-thalassemia or HbS hemoglobinopathies in the current screening program given the fact that genetic testing is not considered for couples with MCV and MCH in the low-risk range. HbF testing could be conducted to prevent these missing cases. © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Related Docs
View other Related Docs
1. Prevalence of Minor Β-Thalassemia Based on Rbc Indices Among Final Suspected Individuals in Premarital Screening Program Referred to Genetic Laboratories, International Journal of Hematology-Oncology and Stem Cell Research (2010)
2. The Pros and Cons of the Fourth Revision of Thalassaemia Screening Programme in Iran, Journal of Medical Screening (2017)
3. Evaluating the Challenges and Opportunities of Screening for Alpha Thalassemia Within the Beta Thalassemia Screening Program in the Islamic Republic of Iran; [بررسی چالشها و فرص تها ی غربالگری آلفا تالاسم ی در برنامهی غربالگری بتا تالاسمی در جمهور ی اسلامی ایران], Journal of Isfahan Medical School (2025)
4. Discrimination of Beta-Thalassemia Minor and Iron Deficiency Anemia by Screening Test for Red Blood Cell Indices, Turkish Journal of Medical Sciences (2012)
5. Determination of the Need for Prenatal Diagnosis in Carriers of Alpha Thalassemia, Journal of Isfahan Medical School (2013)
6. Pre-Marriage Prevention of Thalassaemia: Report of a 100,000 Case Experience in Isfahan, Public Health (1997)
7. Investigation and Comparison of G6pd Enzyme Screening Test Costs for All Newborns With Treatment Costs of Patients With Favism Admitted Due to Hemolysis; [Ispitivanje I Uporedivanje Troskova G6pd Enzimskog Skrining Testa Za Novorodenu Decu U Odnosu Na Troskove Lecenja Pacijenata Sa Favizmom Hospitalizovanih Usled Hemolize], Medicinski Casopis (2020)
8. Prevalence of Anti Hcv Infection in Patients With Beta-Thalassemia in Isfahan-Iran, International Journal of Preventive Medicine (2012)
Experts (# of related papers)
View all Related Experts
Peyman Adibi (4)
Rasoul Salehi (3)
Other Related Docs
9. Cascade Screening and Registry of Familial Hypercholesterolemia in Iran: Rationale and Design, ARYA Atherosclerosis (2019)
10. Attitudes Towards Maternal Screening for Hepatitis B Virus Infection in Iran., Tropical gastroenterology : official journal of the Digestive Diseases Foundation (2010)
11. Comparison of Gestational Diabetes Mellitus and Pre-Eclampsia in Women With High Hemoglobin in the First Trimester of Pregnancy: A Longitudinal Study, Pakistan Journal of Medical Sciences (2013)
12. Prevalence of Hepatitis C Virus, Hepatitis B Virus, Human Immunodeficiency Virus and Related Risk Factors Among Hemophilia and Thalassemia Patients in Iran, Iranian Journal of Clinical Infectious Diseases (2011)
13. Assessment of Nutritional Status and Hematological Indices in Patients With Beta Thalassemia Major, Journal of Zanjan University of Medical Sciences and Health Services (2012)
14. Effectiveness of Twice Weekly Iron Supplementation Compared With Daily Regimen in Reducing Anemia and Iron Deficiency During Pregnancy: A Randomized Trial in Iran, Journal of Research in Medical Sciences (2008)
15. Malignancies in Patients With Β-Thalassemia Major and Β-Thalassemia Intermedia: A Multicenter Study in Iran, Pediatric Blood and Cancer (2009)
16. Family-Based Association Analysis Between Nonsyndromic Cleft Lip With or Without Cleft Palate and Irf6 Polymorphism in an Iranian Population, Clinical Oral Investigations (2015)
17. An Update of Spectrum and Frequency of Gjb2 Mutations Causing Hearing Loss in the South of Iran: A Literature Review, International Journal of Pediatric Otorhinolaryngology (2019)
18. Identification of Three Novel Mutations [-41 (A>C), Codon 24 (G), and Ivs-I-109 (-T)], in a Study of Β-Thalassemia Alleles in the Isfahan Region of Iran, Hemoglobin (2010)
19. The Impact of Maternal Predisposing Factors on Level of Maternal Serum Pregnancy-Associated Plasma Protein a and Free Subunit Human Chorionic Gonadotropin and Nuchal Translucency, Advanced Biomedical Research (2023)
20. Evaluation of the Prevalence and Determinants of Iron Deficiency Anemia in a Sample of Preschool-Aged Children in Isfahan City, Iran, Journal of Isfahan Medical School (2017)
21. Hepatits C and B in Blood Transfusion Recipients Indentified at Isfahan Province, Journal of Isfahan Medical School (2011)
22. Novel Multiplex Fluorescent Pcr-Based Method for Hla Typing and Preimplantational Genetic Diagnosis of Β-Thalassemia, Archives of Medical Research (2016)
23. Global Variation in Diabetes Diagnosis and Prevalence Based on Fasting Glucose and Hemoglobin A1c, Nature Medicine (2023)
24. Attitudes Towards Premarital Screening for Hepatitis B Virus Infection in Iran, Journal of Medical Screening (2007)
25. Prevalence of Anemia According to Some Hematological Parameters Among Reproductive-Age Females in Kermanshah, Western Iran, Journal of Nutrition and Food Security (2019)
26. Prevalence of Microcytic Anemia Among Newborn Infants From Baharloo Hospital, Tehran, Iran, Tehran University Medical Journal (2021)
27. Hypercoagulopathy and Serum “Natural Antithrombotic Factors” in Beta-Thalassemia Major, Journal of Isfahan Medical School (2008)
28. Evaluation of Iron Status by Serum Ferritin Level in Iranian Carriers of Beta Thalassemia Minor, International Journal for Vitamin and Nutrition Research (2008)
29. Detection of Paternally Inherited Fetal Point Mutations for Β-Thalassemia in Maternal Plasma Using Simple Fetal Dna Enrichment Protocol With or Without Whole Genome Amplification: An Accuracy Assessment, Journal of Maternal-Fetal and Neonatal Medicine (2016)
30. Relationship Between False Positive Screening Results of Down Syndrome and Adverse Pregnancy Outcomes, Iranian Journal of Nursing and Midwifery Research (2023)
31. Glucose-6-Phosphate Dehydrogenase Deficiency in Neonates, Indian Journal of Pediatrics (2003)
32. Detection of Ivsii-1 Mutation of Beta Globin Gene in Patients With Thalassemia Minor Using High-Resolution Melting Analysis, Journal of Isfahan Medical School (2016)
33. Association of Deficiency of Coagulation Factors (Prs, Prc, Atiii) and Fvl Positivity With Preeclampsia And/Or Eclampsia in Pregnant Women, International Journal of Hematology-Oncology and Stem Cell Research (2014)
34. The Effect of Simultaneous Administration of Zinc Sulfate and Ferrous Sulfate in the Treatment of Anemic Pregnant Women, Journal of Research in Medical Sciences (2005)
35. Body Mass Index and Its Relationship With Hematological Indices in Iranian Women, Pakistan Journal of Nutrition (2008)
36. Association of Body Mass Index and Serum Ferritin Level in Pediatrics With Beta-Thalassemia Major Disease, Iranian Journal of Pediatric Hematology and Oncology (2022)
37. Glycated Hemoglobin As a Predictor for Metabolic Syndrome in an Iranian Population With Normal Glucose Tolerance, Metabolic Syndrome and Related Disorders (2012)
38. Study of Prenatal Screening Tests in Pregnant Women and Comparison With Fetal Karyotype Results, Iranian Journal of Obstetrics, Gynecology and Infertility (2018)
39. Investigation of Sensitivity, Specificity and Accuracy of Tetra Primer Arms Pcr Method in Comparison With Conventional Arms Pcr, Based on Sequencing Technique Outcomes in Ivs-Ii-I Genotyping of Beta Thalassemia Patients, Gene (2014)
40. Newborn Screening for Inherited Metabolic Disorders; News and Views, Journal of Research in Medical Sciences (2013)
41. Prevalence, Years Lived With Disability, and Trends in Anaemia Burden by Severity and Cause, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet Haematology (2023)